Selected research
Market Structure
Global Stool Biomarkers Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Stool Biomarkers Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Stool Biomarkers Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Stool Biomarkers Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Stool Biomarkers Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Stool Biomarkers Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Stool Biomarkers Test include Genova Diagnostics, BioMrieux Inc, Actim, DiaSorin S.p.A., Beckman Coulter Inc., Alere Inc., Bio Rad Laboratories, Cenogenics Corporation and Siemens Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Stool Biomarkers Test market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Stool Biomarkers Test and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Stool Biomarkers Test revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Stool Biomarkers Test market size, projected growth trends, production technologies, key applications, and end-use industries.
Stool Biomarkers Test Segment by Company
Genova Diagnostics
BioMrieux Inc
Actim
DiaSorin S.p.A.
Beckman Coulter Inc.
Alere Inc.
Bio Rad Laboratories
Cenogenics Corporation
Siemens Healthcare
Quest Diagnostics Incorporated
Abbott Laboratories
Diagnose IBS
Meridian Bioscience Inc
Stool Biomarkers Test Segment by Type
Cologuard
M2 PK Stool Test
Others
Stool Biomarkers Test Segment by Application
Hospitals
Diagnostic Centres and Laboratories
Academic Institutions
Research Centres and Organizations
Stool Biomarkers Test Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stool Biomarkers Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stool Biomarkers Test and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stool Biomarkers Test.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Stool Biomarkers Test in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Stool Biomarkers Test industry.
Chapter 3: Detailed analysis of Stool Biomarkers Test companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Stool Biomarkers Testrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cologuard
- M2 PK Stool Test
- Others
Applications
- Hospitals
- Diagnostic Centres and Laboratories
- Academic Institutions
- Research Centres and Organizations
Companies covered
- Genova Diagnostics
- BioMrieux Inc
- Actim
- DiaSorin S.p.A.
- Beckman Coulter Inc.
- Alere Inc.
- Bio Rad Laboratories
- Cenogenics Corporation
- Siemens Healthcare
- Quest Diagnostics Incorporated
- Abbott Laboratories
- Diagnose IBS
- Meridian Bioscience Inc
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Stool Biomarkers Test Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Cologuard
- 1.2.3 M2 PK Stool Test
- 1.2.4 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Stool Biomarkers Test Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospitals
- 1.3.3 Diagnostic Centres and Laboratories
- 1.3.4 Academic Institutions
- 1.3.5 Research Centres and Organizations
- 1.4 Global Market Growth Prospects
- 1.5 Global Stool Biomarkers Test Growth Trends by Region
- 1.5.1 Global Stool Biomarkers Test Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Stool Biomarkers Test Market Size by Region (2021-2026)
- 1.5.3 Stool Biomarkers Test Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Stool Biomarkers Test Market Dynamics
- 2.1 Stool Biomarkers Test Industry Trends
- 2.2 Stool Biomarkers Test Industry Drivers
- 2.3 Stool Biomarkers Test Industry Opportunities and Challenges
- 2.4 Stool Biomarkers Test Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Stool Biomarkers Test Revenue by Company (2021-2026)
- 3.2 Global Stool Biomarkers Test Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Stool Biomarkers Test Key Company Head office and Area Served
- 3.4 Global Stool Biomarkers Test Company, Product Type & Application
- 3.5 Global Stool Biomarkers Test Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Stool Biomarkers Test Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Stool Biomarkers Test Players Market Share by Revenue in 2025
- 3.6.3 2025 Stool Biomarkers Test Tier 1, Tier 2, and Tier 3
4 Stool Biomarkers Test Market by Type
- 4.1 Global Stool Biomarkers Test Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Stool Biomarkers Test Market Size by Type (2021-2032)
- 4.3 Global Stool Biomarkers Test Market Size Share by Type (2021-2032)
5 Stool Biomarkers Test Market by Application
- 5.1 Global Stool Biomarkers Test Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Stool Biomarkers Test Market Size by Application (2021-2032)
- 5.3 Global Stool Biomarkers Test Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Genova Diagnostics
- 6.1.1 Genova Diagnostics Company Information
- 6.1.2 Genova Diagnostics Business Overview
- 6.1.3 Genova Diagnostics Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Genova Diagnostics Stool Biomarkers Test Product Portfolio
- 6.1.5 Genova Diagnostics Recent Developments
- 6.2 BioMrieux Inc
- 6.2.1 BioMrieux Inc Company Information
- 6.2.2 BioMrieux Inc Business Overview
- 6.2.3 BioMrieux Inc Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 BioMrieux Inc Stool Biomarkers Test Product Portfolio
- 6.2.5 BioMrieux Inc Recent Developments
- 6.3 Actim
- 6.3.1 Actim Company Information
- 6.3.2 Actim Business Overview
- 6.3.3 Actim Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Actim Stool Biomarkers Test Product Portfolio
- 6.3.5 Actim Recent Developments
- 6.4 DiaSorin S.p.A.
- 6.4.1 DiaSorin S.p.A. Company Information
- 6.4.2 DiaSorin S.p.A. Business Overview
- 6.4.3 DiaSorin S.p.A. Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 DiaSorin S.p.A. Stool Biomarkers Test Product Portfolio
- 6.4.5 DiaSorin S.p.A. Recent Developments
- 6.5 Beckman Coulter Inc.
- 6.5.1 Beckman Coulter Inc. Company Information
- 6.5.2 Beckman Coulter Inc. Business Overview
- 6.5.3 Beckman Coulter Inc. Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Beckman Coulter Inc. Stool Biomarkers Test Product Portfolio
- 6.5.5 Beckman Coulter Inc. Recent Developments
- 6.6 Alere Inc.
- 6.6.1 Alere Inc. Company Information
- 6.6.2 Alere Inc. Business Overview
- 6.6.3 Alere Inc. Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Alere Inc. Stool Biomarkers Test Product Portfolio
- 6.6.5 Alere Inc. Recent Developments
- 6.7 Bio Rad Laboratories
- 6.7.1 Bio Rad Laboratories Company Information
- 6.7.2 Bio Rad Laboratories Business Overview
- 6.7.3 Bio Rad Laboratories Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Bio Rad Laboratories Stool Biomarkers Test Product Portfolio
- 6.7.5 Bio Rad Laboratories Recent Developments
- 6.8 Cenogenics Corporation
- 6.8.1 Cenogenics Corporation Company Information
- 6.8.2 Cenogenics Corporation Business Overview
- 6.8.3 Cenogenics Corporation Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Cenogenics Corporation Stool Biomarkers Test Product Portfolio
- 6.8.5 Cenogenics Corporation Recent Developments
- 6.9 Siemens Healthcare
- 6.9.1 Siemens Healthcare Company Information
- 6.9.2 Siemens Healthcare Business Overview
- 6.9.3 Siemens Healthcare Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Siemens Healthcare Stool Biomarkers Test Product Portfolio
- 6.9.5 Siemens Healthcare Recent Developments
- 6.10 Quest Diagnostics Incorporated
- 6.10.1 Quest Diagnostics Incorporated Company Information
- 6.10.2 Quest Diagnostics Incorporated Business Overview
- 6.10.3 Quest Diagnostics Incorporated Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Quest Diagnostics Incorporated Stool Biomarkers Test Product Portfolio
- 6.10.5 Quest Diagnostics Incorporated Recent Developments
- 6.11 Abbott Laboratories
- 6.11.1 Abbott Laboratories Company Information
- 6.11.2 Abbott Laboratories Business Overview
- 6.11.3 Abbott Laboratories Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Abbott Laboratories Stool Biomarkers Test Product Portfolio
- 6.11.5 Abbott Laboratories Recent Developments
- 6.12 Diagnose IBS
- 6.12.1 Diagnose IBS Company Information
- 6.12.2 Diagnose IBS Business Overview
- 6.12.3 Diagnose IBS Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Diagnose IBS Stool Biomarkers Test Product Portfolio
- 6.12.5 Diagnose IBS Recent Developments
- 6.13 Meridian Bioscience Inc
- 6.13.1 Meridian Bioscience Inc Company Information
- 6.13.2 Meridian Bioscience Inc Business Overview
- 6.13.3 Meridian Bioscience Inc Stool Biomarkers Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Meridian Bioscience Inc Stool Biomarkers Test Product Portfolio
- 6.13.5 Meridian Bioscience Inc Recent Developments
7 North America
- 7.1 North America Stool Biomarkers Test Market Size (2021-2032)
- 7.2 North America Stool Biomarkers Test Market Size by Type
- 7.2.1 North America Stool Biomarkers Test Market Size by Type (2021-2026)
- 7.2.2 North America Stool Biomarkers Test Market Size by Type (2027-2032)
- 7.2.3 North America Stool Biomarkers Test Market Share by Type (2021-2032)
- 7.3 North America Stool Biomarkers Test Market Size by Application
- 7.3.1 North America Stool Biomarkers Test Market Size by Application (2021-2026)
- 7.3.2 North America Stool Biomarkers Test Market Size by Application (2027-2032)
- 7.3.3 North America Stool Biomarkers Test Market Share by Application (2021-2032)
- 7.4 North America Stool Biomarkers Test Market Size by Country
- 7.4.1 North America Stool Biomarkers Test Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Stool Biomarkers Test Market Size by Country (2021-2026)
- 7.4.3 North America Stool Biomarkers Test Market Size by Country (2027-2032)
- 7.4.4 North America Stool Biomarkers Test Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Stool Biomarkers Test Market Size (2021-2032)
- 8.2 Europe Stool Biomarkers Test Market Size by Type
- 8.2.1 Europe Stool Biomarkers Test Market Size by Type (2021-2026)
- 8.2.2 Europe Stool Biomarkers Test Market Size by Type (2027-2032)
- 8.2.3 Europe Stool Biomarkers Test Market Share by Type (2021-2032)
- 8.3 Europe Stool Biomarkers Test Market Size by Application
- 8.3.1 Europe Stool Biomarkers Test Market Size by Application (2021-2026)
- 8.3.2 Europe Stool Biomarkers Test Market Size by Application (2027-2032)
- 8.3.3 Europe Stool Biomarkers Test Market Share by Application (2021-2032)
- 8.4 Europe Stool Biomarkers Test Market Size by Country
- 8.4.1 Europe Stool Biomarkers Test Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Stool Biomarkers Test Market Size by Country (2021-2026)
- 8.4.3 Europe Stool Biomarkers Test Market Size by Country (2027-2032)
- 8.4.4 Europe Stool Biomarkers Test Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Stool Biomarkers Test Market Size (2021-2032)
- 9.2 China Stool Biomarkers Test Market Size by Type
- 9.2.1 China Stool Biomarkers Test Market Size by Type (2021-2026)
- 9.2.2 China Stool Biomarkers Test Market Size by Type (2027-2032)
- 9.2.3 China Stool Biomarkers Test Market Share by Type (2021-2032)
- 9.3 China Stool Biomarkers Test Market Size by Application
- 9.3.1 China Stool Biomarkers Test Market Size by Application (2021-2026)
- 9.3.2 China Stool Biomarkers Test Market Size by Application (2027-2032)
- 9.3.3 China Stool Biomarkers Test Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Stool Biomarkers Test Market Size (2021-2032)
- 10.2 Asia Stool Biomarkers Test Market Size by Type
- 10.2.1 Asia Stool Biomarkers Test Market Size by Type (2021-2026)
- 10.2.2 Asia Stool Biomarkers Test Market Size by Type (2027-2032)
- 10.2.3 Asia Stool Biomarkers Test Market Share by Type (2021-2032)
- 10.3 Asia Stool Biomarkers Test Market Size by Application
- 10.3.1 Asia Stool Biomarkers Test Market Size by Application (2021-2026)
- 10.3.2 Asia Stool Biomarkers Test Market Size by Application (2027-2032)
- 10.3.3 Asia Stool Biomarkers Test Market Share by Application (2021-2032)
- 10.4 Asia Stool Biomarkers Test Market Size by Country
- 10.4.1 Asia Stool Biomarkers Test Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Stool Biomarkers Test Market Size by Country (2021-2026)
- 10.4.3 Asia Stool Biomarkers Test Market Size by Country (2027-2032)
- 10.4.4 Asia Stool Biomarkers Test Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Stool Biomarkers Test Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Stool Biomarkers Test Market Size by Type
- 11.2.1 South America, Middle East & Africa Stool Biomarkers Test Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Stool Biomarkers Test Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Stool Biomarkers Test Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Stool Biomarkers Test Market Size by Application
- 11.3.1 South America, Middle East & Africa Stool Biomarkers Test Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Stool Biomarkers Test Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Stool Biomarkers Test Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Stool Biomarkers Test Market Size by Country
- 11.4.1 South America, Middle East & Africa Stool Biomarkers Test Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Stool Biomarkers Test Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Stool Biomarkers Test Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Stool Biomarkers Test Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst